Present Life, a new wellbeing and beauty holding company headed by former Coty, Inc. CEO Camillo Pane, aims to cultivate a portfolio of advanced plant-based brands with positionings from mass retail to luxury.
Former Coty CEO’s Present Life: Banking On CBD, Clean Beauty
Armed with $20m in Series A funding, Present Life aims to disrupt the wellness and beauty market with “clean, benefit-led brands with no compromise on performance or the planet.” Its current portfolio comprises the CBD-powered Healist and LOUM brands, as well as recently acquired One Ocean Beauty.

More from Business
Major Europe-based consumer health players Haleon, Reckitt and Bayer feature in this sales and earnings preview, which highlights what to look out for as these three firms report their Q1 2025 results over the coming weeks.
CRN/Radicle Science expand Trailblazer Award nominations; BodyArmor brand relaunch with ‘Choose Better’ campaign and pro athletes; and Just Ingredients catches Bryce Harper as partner.
“As we progress through 2025, it is clear that we are operating in an increasingly dynamic environment,” says Abbott CEO Robert Ford. Trump’s tariff decisions, the CRN advises dietary supplement and other consumer health product firms, are likely to change.
Iron supplements specialist PharmaNutra has penned distribution deals to take its products to additional markets across the Americas and the Middle East & North Africa.
More from Wellness
FDA introduced the option because it didn’t have sufficient staff to handle the volume of GRAS submission reviews requested by food and other firms for ingredients. Requiring submissions for all GRAS determinations “would just be an unworkable situation for the food industry if somehow submitting notice, submitting notices for FDA review and concurrence, was required,” says food and drug attorney Federick Stearns.
Instead of arguing FDA’s not authorized to offer option under authority from 1958 Food Additives Amendments, potential litigation could contend the law requires agency to continue making self-GRAS without notification available.
France's food safety regulator ANSES is proposing a reproductive toxicity category 1B classification for CBD under the EU's CLP regulation, which would mean an effective ban on CBD in cosmetics and foods. However, French hemp industry association UIVEC hopes that new evidence coming out of a European Commission review will put the issue to bed before it gets that far.